Research Articles | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes Dec 2023 Clinics in Laboratory Medicine myelodysplastic syndromes (MDS)
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going Feb 2014 Transl Med UniSa paroxysmal nocturnal hemoglobinuria (PNH)
Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations Feb 2018 Int J Womens Health aplastic anemia
Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy Apr 2014 Hematol Oncol myelodysplastic syndromes (MDS)
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia Mar 2014 Leuk Res myelodysplastic syndromes (MDS)
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP o Oct 2020 Bone Marrow Transplantation aplastic anemia
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy Feb 2017 Oncotarget myelodysplastic syndromes (MDS)
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study May 2014 Eur J Haematol myelodysplastic syndromes (MDS)
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution Sep 2014 Blood aplastic anemia
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Sep 2014 Blood aplastic anemia
Share with addtoany.com.